NCT02728050
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Acute Biphenotypic Leukemia
Explore clinical trials studying Acute Biphenotypic Leukemia. Study availability and eligibility vary by location and protocol.
26 public trials
5 recruiting studies
Acute Biphenotypic Leukemia trial results
NCT00796068
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +25 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Oregon Health and Science University Portland, Oregon, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02529813
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, +22 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of Colorado Denver, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02044796
- Conditions
- Acute Biphenotypic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01804101
- Conditions
- Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States